|
2018-09-04 |
2018-08-30 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
82.304
-55.6%
27,40
2.255.492 USD
|
82.304
-55.6%
|
27,40
|
2.255.492 USD
|
|
|
2018-08-17 |
2018-08-16 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
1.480
-2.2%
20,08
29.715 USD
|
1.480
-2.2%
|
20,08
|
29.715 USD
|
|
|
2018-08-17 |
2018-08-16 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
695
-3.0%
20,19
14.035 USD
|
695
-3.0%
|
20,19
|
14.035 USD
|
|
|
2018-07-06 |
2018-07-03 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
867
-1.3%
22,47
19.482 USD
|
867
-1.3%
|
22,47
|
19.482 USD
|
|
|
2018-06-08 |
2018-06-08 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
|
455
-2.2%
22,81
10.378 USD
|
455
-2.2%
|
22,81
|
10.378 USD
|
|
|
2017-08-24 |
2017-08-23 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.332
-0.7%
23,30
31.036 USD
|
1.332
-0.7%
|
23,30
|
31.036 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.090
-0.5%
24,08
26.247 USD
|
1.090
-0.5%
|
24,08
|
26.247 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
2.350
-4.1%
24,08
56.588 USD
|
2.350
-4.1%
|
24,08
|
56.588 USD
|
|
|
2017-08-16 |
2017-08-15 |
GV
Geplanter Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
|
770
-4.5%
24,09
18.549 USD
|
770
-4.5%
|
24,09
|
18.549 USD
|
|
|
2017-08-15 |
2017-08-11 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
39.357
-40.6%
23,37
919.631 USD
|
39.357
-40.6%
|
23,37
|
919.631 USD
|
|
|
2017-07-05 |
2017-07-01 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
Führungsperson
|
956
-1.6%
24,33
23.259 USD
|
956
-1.6%
|
24,33
|
23.259 USD
|
|
|
2017-06-16 |
2017-06-16 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
13.787
-19.1%
22,73
313.379 USD
|
13.787
-19.1%
|
22,73
|
313.379 USD
|
|
|
2017-06-16 |
2017-06-15 |
GV
Geplanter Verkauf
|
Cole Gregory S
Chief Financial Officer
|
29.160
-33.4%
22,83
665.723 USD
|
29.160
-33.4%
|
22,83
|
665.723 USD
|
|
|
2017-05-30 |
2017-05-25 |
V
Verkauf
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Geschäftsführender Verwaltungsratsmitglied
|
50.000
-20.1%
22,70
1.135.000 USD
|
50.000
-20.1%
|
22,70
|
1.135.000 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
800
-6.0%
21,77
17.419 USD
|
800
-6.0%
|
21,77
|
17.419 USD
|
|
|
2017-05-15 |
2017-05-12 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
200
-1.5%
21,77
4.354 USD
|
200
-1.5%
|
21,77
|
4.354 USD
|
|
|
2017-05-10 |
2017-05-10 |
V
Verkauf
|
MORATIS GEORGE Z
Global Accounting Officer
Führungsperson
|
902
-6.3%
21,61
19.492 USD
|
902
-6.3%
|
21,61
|
19.492 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Großaktionär
|
3.926.068
-42.2%
20,23
79.424.356 USD
|
3.926.068
-42.2%
|
20,23
|
79.424.356 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
WCAS Capital Partners IV, L.P.
Großaktionär
|
57.488
-42.2%
20,23
1.162.982 USD
|
57.488
-42.2%
|
20,23
|
1.162.982 USD
|
|
|
2017-02-14 |
2017-01-26 |
V
Verkauf
|
WCAS MANAGEMENT CORP
Großaktionär
|
3.214
-42.2%
20,23
65.019 USD
|
3.214
-42.2%
|
20,23
|
65.019 USD
|
|
